Co-beneldopa (Benserazide/levodopa) Prescribing at HOYLAND HOUSE
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
184
Total Quantity
36.6K
NHS Cost
£2.1K
vs National Avg
+21.7%
HOYLAND HOUSE prescribed 184 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £2,114 to the NHS. This is 21.7% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
14
Jul 2026
14
Jul 2026
14
Jul 2026
20
Jul 2026
12
Jul 2026
19
Jul 2026
11
Jul 2026
21
Jul 2026
18
Jul 2026
12
Jul 2026
17
Jul 2026
12
Prescribing Details
| Total Items | 184 |
|---|---|
| Total Quantity | 36,600 |
| Total NHS Cost | £2,114 |
| Presentations | 10 different forms |
| vs National Average | +21.7% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 184 items |
|---|---|
| National average per practice | 151 items |
| Difference | +21.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.